Status:
RECRUITING
Evaluation of the Individual Early Psychoeducation Program for Schizophrenic Disorders in Inpatients
Lead Sponsor:
University Hospital, Tours
Conditions:
Schizophrenia
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Schizophrenia affects about 0.7% of the population. Poor insight, which is common in this disease, linked to poor drug compliance is leads to rehospitalisation with major impact on quality of life. In...
Eligibility Criteria
Inclusion
- Age between 18 and 65 years
- Patient with a diagnosed and reported schizophrenic disorder announced :
- Schizophrenia
- Schizoaffective disorder
- Or a diagnosed and reported Delusional Disorder
- Express written consent by the participant after receiving information about the study
- Be able to communicate verbally
- Participant affiliated to a social security scheme
Exclusion
- Pregnant or breastfeeding woman
- Patient who does not speak French
- Participation in a psycho-education group in the last 2 years
- Patient under legal protection or guardianship
Key Trial Info
Start Date :
June 17 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2027
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT05329363
Start Date
June 17 2022
End Date
June 1 2027
Last Update
April 23 2024
Active Locations (11)
Enter a location and click search to find clinical trials sorted by distance.
1
Serrvice de Psychiatrie
Blois, France
2
Service de psychiatrie
Chinon, France
3
Service de psychiatrie
Dreux, France
4
Service de psychiatrie
Fleury-les-Aubrais, France